Does an Integrated Care Pathway enhance the management of diabetic ketoacidosis?

Diabetic Medicine

Volumn 24, Issue 4, 2007, Pages 359-363

  Waller, S L ^a   Delaney, S ^a   Strachan, M W J ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diabetic ketoacidosis; Integrated Care Pathway

Indexed keywords

ANTIBIOTIC AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; POTASSIUM;

ADOLESCENT; ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA EXTRACTION; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; INSULIN INFUSION; INTRAVENOUS ADMINISTRATION; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRESCRIPTION; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; CRITICAL PATHWAYS; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); TIME FACTORS; TREATMENT OUTCOME;

EID: 33947375690     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02102.x     Document Type: Article

References (10)

1. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR et al. The British Diabetic Association cohort study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 466-471.
2. Strachan MWJ, Nimmo GR, Noyes K, Simpson D, Kelnar CJ. Management of cerebral oedema in diabetes. Diabetes Metab Res Rev 2003; 19: 241-247.
3. European IDDM Policy Group. Consensus guidelines for the management of insulin-dependent (Type 1) diabetes. Diabet Med 1993; 10: 990-1005.
4. Singh RK, Perros P, Frier BM. Hospital management of diabetic ketoacidosis: are clinical guidelines implemented effectively? Diabet Med 1997; 14: 482-486.
5. Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med 1995; 123: 941-948.
6. Every NR, Hochman J, Becker R, Kopecky S, Cannon CP. Critical pathways: a review. Circulation 2000; 101: 461-465.
7. Dy SM, Garg P, Nyberg D, Dawson PB, Pronovost PJ, Morlock L et al. Critical pathway effectiveness: assessing the impact of the patient, hospital and pathway characteristics using qualitative comparative analysis. Health Serv Res 2005; 40: 499-516.
8. Ilag LL, Kronick S, Ernst RD, Grondin L, Alaniz C, Liu L et al. Impact of a critical pathway on inpatient management of diabetic ketoacidosis. Diabetes Res Clinl Prac 2003; 62: 23-32.
9. McGeoch SC, Philip S, Park C, MacRury S, Pearson DWM. Introducing a new protocol for the management of diabetic ketoacidosis in a medical admissions unit. Diabet Med 2006; 23: 81.
10. Lothian Diabetes Network. Local guidelines. 2006 Available from: http://www.lotdiabetnet.scot.nhs.uk (accessed 29 January 2007).